NFG
PMVP icon

Next Financial Group’s PMV Pharmaceuticals PMVP Stock Holding History

Next Financial Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$4K Hold
170
– – ﹤0.01% 2486
2021
Q3 		$5K Buy
+170
New +$5.43K ﹤0.01% 2269

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Next Financial Group's PMVP Position: Q4 2021 in Review

Next Financial Group held its PMV Pharmaceuticals (PMVP) position steady in Q4 2021 at 170 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2486.

Next Financial Group first reported a position in PMVP in Q3 2021 and has held it in 2 quarters since. The position peaked at $5K in Q3 2021. 105 funds tracked by Wall St. Rank hold PMVP as of Q4 2021.

  • Next Financial Group held 170 shares of PMV Pharmaceuticals worth $4K as of Q4 2021.
  • Next Financial Group left its PMV Pharmaceuticals share count unchanged in Q4 2021.
  • PMV Pharmaceuticals made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2486 holding.
  • Next Financial Group first reported a position in PMV Pharmaceuticals in Q3 2021 and has held it in 2 quarters since.
  • Next Financial Group's PMV Pharmaceuticals position peaked at $5K in Q3 2021.
  • 105 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.